株探米国株
日本語 英語
エドガーで原本を確認する
0001443669FALSE00014436692023-11-032023-11-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 3, 2023
Proto Labs, Inc.
(Exact name of registrant as specified in its charter)
Minnesota 001-35435 41-1939628
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer
Identification Number)
5540 Pioneer Creek Drive
Maple Plain, Minnesota
55359
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:
(763) 479-3680
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share PRLB New York Stock Exchange
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02. Results of Operations and Financial Condition.
On November 3, 2023, Proto Labs, Inc. issued a press release announcing its third quarter 2023 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
99.1
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Proto Labs, Inc.
Date:
November 3, 2023
By: /s/ Daniel Schumacher
Daniel Schumacher
Chief Financial Officer

EX-99.1 2 prlb-20231103xexx991.htm EX-99.1 Document

Exhibit 99.1
logoa.jpg
logo1a.jpg
Protolabs Reports Financial Results for the Third Quarter of 2023
Record Revenue of $130.7 million in the Third Quarter
Record Network Revenue of $22.6 million; an 87% YoY increase
GAAP Earnings Per Share of $0.31; Non-GAAP Earnings Per Share of $0.51
MAPLE PLAIN, Minn. – November 3, 2023 – Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the third quarter ended September 30, 2023.
Third Quarter 2023 Highlights:
•Revenue for the third quarter of 2023 was a record $130.7 million, representing a 7.4% increase over the third quarter of 2022.
•Revenue generated from the digital network, powered by Hubs, was $22.6 million in the third quarter, representing growth of 86.9% over the third quarter of the prior year.
•Net income for the third quarter of 2023 was $8.0 million, or $0.31 per diluted share.
•Non-GAAP net income was $13.2 million, or $0.51 per diluted share. See “Non-GAAP Financial Measures” below.
"Protolabs produced third quarter financial results that surpassed our expectations on the top and bottom line. We generated record revenue, improved profitability, generated substantial cash flow, and returned capital to shareholders." said Rob Bodor, President and Chief Executive Officer. "This excellent financial performance demonstrates the success of our strategy; Protolabs' unique hybrid model combining the digital factory and the digital network is the best way to grow profitably in our industry. We experienced increased demand for our comprehensive digitally-enabled manufacturing capabilities in the quarter. The model is winning and customers are delighted."
Additional Third Quarter 2023 Highlights:
•Protolabs served 23,080 unique product developers during the quarter.
•Gross margin was 45.4% in the third quarter of 2023, up sequentially from 43.4% in the second quarter of 2023.
•Non-GAAP gross margin was 46.0% in the third quarter of 2023, representing a sequential increase of 190 basis points. See “Non-GAAP Financial Measures” below.
•EBITDA was $19.5 million, or 14.9% of revenue, in the third quarter of 2023, compared to $11.4 million, or 9.3% of revenue, in the second quarter of 2023. See “Non-GAAP Financial Measures” below.
•Adjusted EBITDA was $23.9 million, or 18.3% of revenue, in the third quarter of 2023, compared to $19.2 million, or 15.7% of revenue, in the second quarter of 2023. See “Non-GAAP Financial Measures” below.
•Cash flow from operations was $24.2 million in the third quarter of 2023, compared to $9.3 million in the second quarter of 2023.
•The Company repurchased $9.0 million of shares during the quarter.
•Cash and investments balance was $114.9 million as of September 30, 2023.
"Along with record revenue in the third quarter, we made substantial progress on our priority to improve profitability in both the digital factory and the digital network," said Dan Schumacher, Chief Financial Officer. "Through a challenging macro environment, Protolabs has demonstrated the industry-leading earnings power and cash flow generation of our business model, enabling us to continue to invest in future growth and return capital to shareholders." The Company has included non-GAAP revenue growth by region and by service line that excludes the impact of changes in foreign currency exchange rates (collectively, “non-GAAP revenue growth”).



Non-GAAP Financial Measures
Management believes these metrics, when viewed in conjunction with the comparable GAAP metrics, are useful in evaluating the underlying business trends and ongoing operating performance of the Company.
The Company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency and costs related to the Japan closure activities (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the Company’s financial results. The Company has also included earnings before interest, taxes, depreciation and amortization margin (“EBITDA margin”) and EBITDA margin, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency and costs related to the Japan closure activities (collectively, “Adjusted EBITDA margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP gross margin, adjusted for stock-based compensation expense and amortization expense in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense and costs related to the closure of Japan (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP gross margin excluding Japan, adjusted for stock-based compensation expense and amortization expense in this press release to provide investors with additional information regarding the Company’s financial results. The Company has included non-GAAP operating margin excluding Japan, adjusted for stock-based compensation expense, amortization expense, and costs related to the Japan closure activities (collectively, “non-GAAP operating margin excluding Japan”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and costs related to the closure of Japan (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP gross margin, non-GAAP gross margin excluding Japan, non-GAAP operating margin, non-GAAP operating margin excluding Japan, non-GAAP revenue growth by region and by service, and Adjusted EBITDA and Adjusted EBITDA margin, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the Company’s management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the Company’s business. Accordingly, the Company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.
Conference Call
The Company has scheduled a conference call to discuss its third quarter 2023 financial results and fourth quarter 2023 outlook today, November 3, 2023 at 8:30 a.m. EDT. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/ic4eziw6. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.
About Protolabs
Protolabs is the fastest and most comprehensive digital manufacturing service in the world. Our digital factories produce low-volume parts in days while our digital network of manufacturing partners powered by Hubs unlocks advanced capabilities and volume pricing at higher quantities. The result? One manufacturing source—from prototyping to production—for product developers, engineers, and supply chain teams across the globe. See what's next at protolabs.com.



Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.
Source: Proto Labs, Inc.
Investor Relations Contact
Protolabs
Ryan Johnsrud, 612-225-4873
Manager – Investor Relations and FP&A
ryan.johnsrud@protolabs.com
Media Contact
Protolabs
Brent Renneke, 763-479-7704
PR & Media Strategist
brent.renneke@protolabs.com



Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
September 30,
2023
December 31,
2022
(Unaudited)
Assets
Current assets
Cash and cash equivalents $ 83,496  $ 56,558 
Short-term marketable securities 19,204  23,568 
Accounts receivable, net 78,395  76,225 
Inventory 13,803  13,578 
Income taxes receivable 891  4,042 
Prepaid expenses and other current assets 8,722  12,597 
Total current assets 204,511  186,568 
Property and equipment, net 243,022  257,785 
Goodwill 273,991  273,991 
Other intangible assets, net 26,668  31,250 
Long-term marketable securities 12,212  26,419 
Operating lease assets 2,737  3,844 
Finance lease assets 16,763  17,532 
Other long-term assets 4,341  4,779 
Total assets $ 784,245  $ 802,168 
Liabilities and shareholders' equity    
Current liabilities    
Accounts payable $ 17,922  $ 17,356 
Accrued compensation 16,337  12,743 
Accrued liabilities and other 21,027  22,384 
Current operating lease liabilities 1,568  1,561 
Current finance lease liabilities 16,630  17,537 
Income taxes payable 1,144  — 
Total current liabilities 74,628  71,581 
Long-term operating lease liabilities 1,545  2,255 
Long-term finance lease liabilities 671  — 
Long-term deferred tax liabilities 17,138  26,322 
Other long-term liabilities 5,341  4,362 
Shareholders' equity 684,922  697,648 
Total liabilities and shareholders' equity $ 784,245  $ 802,168 



Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Revenue
Injection Molding $ 51,688  $ 48,940  $ 152,455  $ 155,693 
CNC Machining 52,916  47,489  149,317  141,809 
3D Printing 21,622  19,823  63,952  59,458 
Sheet Metal 4,291  5,219  12,478  15,066 
Other Revenue 188  250  627  765 
Total Revenue 130,705  121,721  378,829  372,791 
Cost of revenue 71,423  68,089  212,648  205,933 
Gross profit 59,282  53,632  166,181  166,858 
Operating expenses
Marketing and sales 21,682  20,594  65,863  62,235 
Research and development 10,105  9,309  30,647  29,316 
General and administrative 17,058  16,477  49,713  49,770 
Closure of Japan business 22  1,194  186  6,388 
Total operating expenses 48,867  47,574  146,409  147,709 
Income from operations 10,415  6,058  19,772  19,149 
Other income (loss), net 320  (24) (1,758) (323)
Income before income taxes 10,735  6,034  18,014  18,826 
Provision for income taxes 2,781  2,083  7,784  7,223 
Net income $ 7,954  $ 3,951  $ 10,230  $ 11,603 
Net income per share:
Basic $ 0.31  $ 0.14  $ 0.39  $ 0.42 
Diluted $ 0.31  $ 0.14  $ 0.39  $ 0.42 
Shares used to compute net income per share:
Basic 26,023,830 27,505,097 26,296,304 27,512,057
Diluted 26,028,456 27,508,217 26,327,606 27,522,734



Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Nine Months Ended
September 30,
2023 2022
Operating activities
Net income $ 10,230  $ 11,603 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 28,213  29,981 
Stock-based compensation expense 11,811  13,335 
Deferred taxes (9,197) (8,920)
Interest on finance lease obligations 859 
Loss on foreign currency translation 3,906 
Impairments related to closure of Japan business 2,842 
Gain on disposal of property and equipment (498) (1,174)
Other 122  11 
Changes in operating assets and liabilities: 10,600  3,886 
Net cash provided by operating activities 56,046  51,564 
Investing activities
Purchases of property, equipment and other capital assets (9,935) (16,414)
Proceeds from sales of property, equipment and other capital assets 693  3,227 
Purchases of marketable securities (45,872)
Proceeds from sales of marketable securities 1,998 
Proceeds from call redemptions and maturities of marketable securities 19,115  13,696 
Net cash provided by (used in) investing activities 9,873  (43,365)
Financing activities
Proceeds from exercises of stock options 1,986  2,311 
Purchases of shares withheld for tax obligations (1,436) (1,615)
Repurchases of common stock (39,053) (13,074)
Principal repayments of finance lease obligations (234) (417)
Net cash used in financing activities (38,737) (12,795)
Effect of exchange rate changes on cash and cash equivalents (244) (1,972)
Net increase (decrease) in cash and cash equivalents 26,938  (6,568)
Cash and cash equivalents, beginning of period 56,558  65,929 
Cash and cash equivalents, end of period $ 83,496  $ 59,361 



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and costs related to Japan closure activities
GAAP net income $ 7,954  $ 3,951  $ 10,230  $ 11,603 
Add back:
Stock-based compensation expense 4,441  4,907  11,811  13,335 
Amortization expense 1,461  1,510  4,471  4,582 
Unrealized (gain) loss on foreign currency (29) 382  86  742 
Costs related to Japan closure activities 22  1,194  4,093  6,388 
Total adjustments 1
5,895  7,993  20,461  25,047 
Income tax benefits on adjustments 2
(633) (1,060) (931) (2,518)
Non-GAAP net income $ 13,216  $ 10,884  $ 29,760  $ 34,132 
Non-GAAP net income per share:
Basic $ 0.51  $ 0.40  $ 1.13  $ 1.24 
Diluted $ 0.51  $ 0.40  $ 1.13  $ 1.24 
Shares used to compute non-GAAP net income per share:
Basic 26,023,830 27,505,097 26,296,304 27,512,057
Diluted 26,028,456 27,508,217 26,327,606 27,522,734
1Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and costs related to Japan closure activities were included in the following GAAP consolidated statement of operations categories:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Cost of revenue $ 805  $ 902  $ 2,416  $ 2,701 
Marketing and sales 961  929  2,508  2,479 
Research and development 675  602  1,888  1,702 
General and administrative 3,461  3,984  9,471  11,035 
Closure of Japan business 22  1,194  186  6,388 
Total operating expenses 5,119  6,709  14,053  21,604 
Other income (loss), net (29) 382  3,992  742 
Total adjustments $ 5,895  $ 7,993  $ 20,461  $ 25,047 
2For the three and nine months ended September 30, 2023 and 2022, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter.



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Gross Margin
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Revenue $ 130,705  $ 121,721  $ 378,829  $ 372,791 
Gross profit 59,282  53,632  166,181  166,858 
GAAP gross margin 45.4  % 44.1  % 43.9  % 44.8  %
Add back:    
Stock-based compensation expense 462  560  1,388  1,674 
Amortization expense 343  342  1,028  1,027 
Total adjustments 805  902  2,416  2,701 
Non-GAAP gross profit $ 60,087  $ 54,534  $ 168,597  $ 169,559 
Non-GAAP gross margin 46.0  % 44.8  % 44.5  % 45.5  %
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Gross Margin Excluding Japan
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Revenue $ 130,705  $ 121,721  $ 378,829  $ 372,791 
Revenue excluding Japan $ 130,705  $ 120,434  $ 378,829  $ 364,562 
Gross profit 59,282  53,632  166,181  166,858 
GAAP gross margin 45.4  % 44.1  % 43.9  % 44.8  %
Less: Japan gross profit 47  3,150 
Gross Profit excluding Japan 59,282  53,585  166,181  163,708 
GAAP gross margin excluding Japan 45.4  % 44.5  % 43.9  % 44.9  %
Add back:
Stock-based compensation expense 462  560  1,388  1,674 
Amortization expense 343  342  1,028  1,027 
Less:
Japan stock-based compensation expense 13  61 
Japan amortization expense
Total adjustments 805  889  2,416  2,640 
Non-GAAP gross profit excluding Japan $ 60,087  $ 54,474  $ 168,597  $ 166,348 
Non-GAAP gross margin excluding Japan 46.0  % 45.2  % 44.5  % 45.6  %



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Revenue $ 130,705  $ 121,721  $ 378,829  $ 372,791 
Income from operations 10,415  6,058  19,772  19,149 
GAAP operating margin 8.0  % 5.0  % 5.2  % 5.1  %
Add back:
Stock-based compensation expense 4,441  4,907  11,811  13,335 
Amortization expense 1,461  1,510  4,471  4,582 
Costs related to Japan closure activities 22  1,194  186  6,388 
Total adjustments 5,924  7,611  16,468  24,305 
Non-GAAP income from operations $ 16,339  $ 13,669  $ 36,240  $ 43,454 
Non-GAAP operating margin 12.5  % 11.2  % 9.6  % 11.7  %
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin Excluding Japan
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Revenue $ 130,705  $ 121,721  $ 378,829  $ 372,791 
Revenue excluding Japan $ 130,705  $ 120,434  $ 378,829  $ 364,562 
Income from operations 10,415  6,058  19,772  19,149 
GAAP operating margin 8.0  % 5.0  % 5.2  % 5.1  %
Less: Japan (loss) income from operations (7) (724) (481) (720)
Income from operations excluding Japan 10,422  6,782  20,253  19,869 
GAAP operating margin excluding Japan 8.0  % 5.6  % 5.3  % 5.5  %
Add back:
Stock-based compensation expense 4,441  4,907  11,811  13,335 
Amortization expense 1,461  1,510  4,471  4,582 
Costs related to Japan closure activities 22  1,194  186  6,388 
Less:
Japan stock-based compensation expense 89  17  386 
Japan amortization expense
Total adjustments 5,924  7,522  16,451  23,919 
Non-GAAP income from operations excluding Japan $ 16,346  $ 14,304  $ 36,704  $ 43,788 
Non-GAAP operating margin excluding Japan 12.5  % 11.9  % 9.7  % 12.0  %



Proto Labs, Inc.
Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Revenue $ 130,705  $ 121,721  $ 378,829  $ 372,791 
GAAP net income 7,954  3,951  10,230  11,603 
GAAP net income margin 6.1  % 3.2  % 2.7  % 3.1  %
Add back:
Amortization expense $ 1,461  $ 1,510  $ 4,471  $ 4,582 
Depreciation expense 7,869  8,197  23,742  25,399 
Interest income, net (561) (265) (1,283) (459)
Provision for income taxes 2,781  2,083  7,784  7,223 
EBITDA 19,504  15,476  44,944  48,348 
EBITDA Margin 14.9  % 12.7  % 11.9  % 13.0  %
Add back:
Stock-based compensation expense 4,441  4,907  11,811  13,335 
Unrealized (gain) loss on foreign currency (29) 382  86  742 
Costs related to Japan closure activities 22  1,194  4,093  6,388 
Total adjustments 4,434  6,483  15,990  20,465 
Adjusted EBITDA $ 23,938  $ 21,959  $ 60,934  $ 68,813 
Adjusted EBITDA Margin 18.3  % 18.0  % 16.1  % 18.5  %



Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Region
(In thousands)
(Unaudited)
Three Months Ended
September 30, 2023
Three Months Ended September 30, 2022
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
United States $ 103,940  $ $ 103,940  $ 98,970  5.0  % 5.0  %
Europe 26,765  (1,666) 25,099  21,464  24.7  % 16.9  %
Japan 1,287  (100.0  %) (100.0  %)
Total revenue $ 130,705  $ (1,666) $ 129,039  $ 121,721  7.4  % 6.0  %
Nine Months Ended
September 30, 2023
Nine Months Ended September 30, 2022
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
United States $ 298,007  $ $ 298,007  $ 295,121  1.0  % 1.0  %
Europe 80,822  1,311  82,133  69,441  16.4  % 18.3  %
Japan 8,229  (100.0  %) (100.0  %)
Total revenue $ 378,829  $ 1,311  $ 380,140  $ 372,791  1.6  % 2.0  %

1Revenue for the three and nine months ended September 30, 2023 has been recalculated using 2022 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2022 to GAAP revenue for the three and nine months ended September 30, 2023.
3This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2022 to non-GAAP revenue for the three and nine months ended September 30, 2023 (as recalculated using the foreign currency exchange rates in effect during the three and nine months ended September 30, 2022) in order to provide a constant-currency comparison.



Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Service Line
(In thousands)
(Unaudited)
Three Months Ended
September 30, 2023
Three Months Ended September 30, 2022
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
Injection Molding $ 51,688  $ (655) $ 51,033  $ 48,940  5.6  % 4.3  %
CNC Machining 52,916  (708) 52,208  47,489  11.4  9.9 
3D Printing 21,622  (390) 21,232  19,823  9.1  7.1 
Sheet Metal 4,291  (20) 4,271  5,219  (17.8) (18.2)
Other Revenue 188  107  295  250  (24.8) 18.0 
Total Revenue $ 130,705  $ (1,666) $ 129,039  $ 121,721  7.4  % 6.0  %

Nine Months Ended
September 30, 2023
Nine Months Ended September 30, 2022
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
Injection Molding $ 152,455  $ 781  $ 153,236  $ 155,693  (2.1) % (1.6) %
CNC Machining 149,317  152  149,469  141,809  5.3  5.4 
3D Printing 63,952  277  64,229  59,458  7.6  8.0 
Sheet Metal 12,478  (9) 12,469  15,066  (17.2) (17.2)
Other Revenue 627  110  737  765  (18.0) (3.7)
Total Revenue $ 378,829  $ 1,311  $ 380,140  $ 372,791  1.6  % 2.0  %
1Revenue for the three and nine months ended September 30, 2023 has been recalculated using 2022 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2022 to GAAP revenue for the three and nine months ended September 30, 2023.
3This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2022 to non-GAAP revenue for the three and nine months ended September 30, 2023 (as recalculated using the foreign currency exchange rates in effect during the three and nine months ended September 30, 2022) in order to provide a constant-currency comparison.



Proto Labs, Inc.
Product Developer Information
(Unaudited)
Three months ended September 30, Nine months ended September 30,
2023 2022 2023 2022
Unique product developers and engineers served 23,080 23,816 45,668 47,793